{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:02:34Z","timestamp":1769342554062,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ad.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:11:52Z","timestamp":1602292312000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Linfomas cut\u00e1neos. Parte II: otros linfomas cut\u00e1neos"],"prefix":"10.1016","volume":"112","author":[{"given":"R.M.","family":"Pujol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2020.09.005_bib0210","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"EORTC cutaneous lymphoma group subcutaneous panniculitis-like T-cell lymphoma: Definition, classification, and prognostic factors: An EORTC Cutaneous Lymphoma Group study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.ad.2020.09.005_bib0215","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: A conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0220","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.ad.2020.09.005_bib0225","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: A clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0230","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.ad.2020.09.005_bib0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.path.2017.01.003","article-title":"Cutaneous lymphomas with cytotoxic phenotype","volume":"10","author":"Garc\u00eda-Herrera","year":"2017","journal-title":"Surg Pathol Clin."},{"key":"10.1016\/j.ad.2020.09.005_bib0240","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med."},{"key":"10.1016\/j.ad.2020.09.005_bib0245","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jaad.2013.11.028","article-title":"Clinicopathologic and molecular features in cutaneous extranodal natural killer-\/T-cell lymphoma, nasal type, with aggressive and indolent course","volume":"70","author":"Fried","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1684\/ejd.2017.3205","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: A Spanish multicentric retrospective survey","volume":"8","author":"Rozas-Mu\u00f1oz","year":"2018","journal-title":"Eur J Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","article-title":"Cutaneous EBV-related lymphoproliferative disorders","volume":"34","author":"Gru","year":"2017","journal-title":"Semin Diagn Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0260","first-page":"553","article-title":"Cutaneous peripheral T-cell lymphomas, unspecified\/NOS and rare subtypes: A heterogeneous group of challenging cutaneous lymphomas","volume":"147","author":"Kempf","year":"2012","journal-title":"G Ital Dermatol Venereol."},{"key":"10.1016\/j.ad.2020.09.005_bib0265","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8\u2013 positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathologic entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0270","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: A cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology."},{"key":"10.1016\/j.ad.2020.09.005_bib0275","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0285","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: A heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2020.09.005_bib0290","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.ad.2020.09.005_bib0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cll.2017.05.009","article-title":"Primary cutaneous B-cell lymphomas","volume":"37","author":"Hope","year":"2017","journal-title":"Clin Lab Med."},{"key":"10.1016\/j.ad.2020.09.005_bib0300","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ajh.25224","article-title":"Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management","volume":"93","author":"Wilcox","year":"2018","journal-title":"Am J Hematol."},{"key":"10.1016\/j.ad.2020.09.005_bib0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.semdp.2016.11.006","article-title":"Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma","volume":"34","author":"Hope","year":"2017","journal-title":"Semin Diagn Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: An update. Part 2: B-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0315","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0320","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.ad.2020.09.005_bib0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"G\u00e1ng\u00f3","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ad.2020.09.005_bib0330","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/cup.12509","article-title":"Rethinking primary cutaneous marginal zone lymphoma: Shifting the focus to the cause of the infiltrate","volume":"42","author":"Guitart","year":"2015","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0335","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamadermatol.2013.9223","article-title":"High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas","volume":"150","author":"Guitart","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0340","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2013.04.047","article-title":"Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients","volume":"69","author":"Servitje","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0345","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/path.1711","article-title":"FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma","volume":"205","author":"Schreuder","year":"2005","journal-title":"J Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0355","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0360","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","article-title":"Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy","volume":"57","author":"Akhtari","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.ad.2020.09.005_bib0365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2012.10902.x","volume":"167","author":"Penate","year":"2012","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0370","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/his.13832","article-title":"Primary cutaneous large B-cell lymphomas: Relevance of the 2017 World Health Organization classification: Clinicopathological and molecular analyses of 64 cases","volume":"74","author":"Menguy","year":"2019","journal-title":"Histopathology."},{"key":"10.1016\/j.ad.2020.09.005_bib0375","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: Clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0380","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, Leg-type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2020.09.005_bib0385","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2020.09.005_bib0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the\u2019cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol."},{"key":"10.1016\/j.ad.2020.09.005_bib0395","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer \u2014A study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2020.09.005_bib0400","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/107327481402100404","article-title":"Blastic plasmacytoid dendritic cell neoplasm: Update on molecular biology, diagnosis, and therapy","volume":"21","author":"Riaz","year":"2014","journal-title":"Cancer Control."},{"key":"10.1016\/j.ad.2020.09.005_bib0405","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2020.09.005_bib0410","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020303823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731020303823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:10:25Z","timestamp":1757553025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731020303823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0001731020303823"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2020.09.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linfomas cut\u00e1neos. Parte II: otros linfomas cut\u00e1neos","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}